These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27284088)

  • 1. Re: To K, Zhao Y, Jiang H, Hu K, Wang M, Wu J, Lee C, Yokom DW, Stratford AL, Klinge U, Mertens PR, Chen CS, Bally M, Yapp D, and Dunn SE (2007) The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor. Mol Pharmacol 72:641-652; doi:10.1124/mol.107.036111.
    Mol Pharmacol; 2016 Jul; 90(1):61. PubMed ID: 27284088
    [No Abstract]   [Full Text] [Related]  

  • 2. The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.
    To K; Zhao Y; Jiang H; Hu K; Wang M; Wu J; Lee C; Yokom DW; Stratford AL; Klinge U; Mertens PR; Chen CS; Bally M; Yapp D; Dunn SE
    Mol Pharmacol; 2007 Sep; 72(3):641-52. PubMed ID: 17595327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase.
    Porchia LM; Guerra M; Wang YC; Zhang Y; Espinosa AV; Shinohara M; Kulp SK; Kirschner LS; Saji M; Chen CS; Ringel MD
    Mol Pharmacol; 2007 Nov; 72(5):1124-31. PubMed ID: 17673571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OSU-03012 promotes caspase-independent but PERK-, cathepsin B-, BID-, and AIF-dependent killing of transformed cells.
    Yacoub A; Park MA; Hanna D; Hong Y; Mitchell C; Pandya AP; Harada H; Powis G; Chen CS; Koumenis C; Grant S; Dent P
    Mol Pharmacol; 2006 Aug; 70(2):589-603. PubMed ID: 16622074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor.
    Tseng PH; Wang YC; Weng SC; Weng JR; Chen CS; Brueggemeier RW; Shapiro CL; Chen CY; Dunn SE; Pollak M; Chen CS
    Mol Pharmacol; 2006 Nov; 70(5):1534-41. PubMed ID: 16887935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disrupting Y-Box-Binding Protein 1 Function Using OSU-03012 Prevents Endometriosis Progression in In Vitro and In Vivo Models.
    Silveira CGT; Marschner G; Canny GO; Klocke S; Hunold P; Köster F; Ahrens T; Rody A; Hornung D
    Reprod Sci; 2017 Jan; 24(1):67-76. PubMed ID: 27217374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OSU-03012 stimulates PKR-like endoplasmic reticulum-dependent increases in 70-kDa heat shock protein expression, attenuating its lethal actions in transformed cells.
    Park MA; Yacoub A; Rahmani M; Zhang G; Hart L; Hagan MP; Calderwood SK; Sherman MY; Koumenis C; Spiegel S; Chen CS; Graf M; Curiel DT; Fisher PB; Grant S; Dent P
    Mol Pharmacol; 2008 Apr; 73(4):1168-84. PubMed ID: 18182481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphoinositide-dependent protein kinase 1 inhibitor, UCN-01, induces fragmentation: possible role of metalloproteinases.
    Alcántara-Hernández R; Hernández-Méndez A; García-Sáinz JA
    Eur J Pharmacol; 2014 Oct; 740():88-96. PubMed ID: 25016091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OSU-03012 in the treatment of glioblastoma.
    McCubrey JA; Lahair MM; Franklin RA
    Mol Pharmacol; 2006 Aug; 70(2):437-9. PubMed ID: 16675657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of phosphoinositide-dependent kinase-1 in α1B-adrenoceptor phosphorylation and desensitization.
    Alcántara Hernández R; García-Sáinz JA
    Eur J Pharmacol; 2012 Jan; 674(2-3):179-87. PubMed ID: 22134004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on "Olive oil intake and cardiovascular disease, cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective cohort studies" by Y. Ke, H. Fan, Y. Zhao, X. Fu, M. Wang, Y. Gao, Y. Chen, W. Huo, W. Zhang, L. Wang, Y. Wu, X. Li, D. Zhang, F. Hu, M. Zhang, L. Sun, J. Lu and D. Hu,
    Zhao Y; Wang Q
    Food Funct; 2024 Aug; 15(17):8952-8954. PubMed ID: 39150532
    [No Abstract]   [Full Text] [Related]  

  • 12. A new name and seventeen new combinations in the Magnolia (Magnoliaceae) of China and Vietnam.
    Callaghan C; Png SS
    Bot Stud; 2013 Dec; 54(1):53. PubMed ID: 28510891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of the scintillator-based probe for fast-ion losses in the HL-2A tokamak.
    Zhang YP; Liu Y; Luo XB; Isobe M; Yuan GL; Liu YQ; Hua Y; Song XY; Yang JW; Li X; Chen W; Li Y; Yan LW; Song XM; Yang QW; Duan XR
    Rev Sci Instrum; 2014 May; 85(5):053502. PubMed ID: 24880364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: The Effect of Nerve Sparing Status on Sexual and Urinary Function: 3-Year Results from the CEASAR Study: S. Avulova, Z. Zhao, D. Lee, L. C. Huang, T. Koyama, K. E. Hoffman, R. M. Conwill, X. C. Wu, V. Chen, M. R. Cooperberg, M. Goodman, S. Greenfield, A. S. Hamilton, M. Hashibe, L. E. Paddock, A. Stroup, M. J. Resnick, D. F. Penson and D. A. Barocas J Urol 2018;199:1202-1209.
    Ramakrishnan VM; Bossert K; Lehmann KH; Hefermehl LJ
    J Urol; 2018 Nov; 200(5):1124-1125. PubMed ID: 30059667
    [No Abstract]   [Full Text] [Related]  

  • 15. A structural study of 4-aminoantipyrine and six of its Schiff base derivatives.
    Mnguni MJ; Lemmerer A
    Acta Crystallogr C Struct Chem; 2015 Feb; 71(Pt 2):103-9. PubMed ID: 25652276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Ling Y-H, Li T, Yuan Z, Haigentz M, Jr., Weber TK, and Perez-Soler R (2007) Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27KIP1 Up-Regulation and Nuclear Translocation in Association with Cell Growth Inhibition and G1/S Phase Arrest in Human Non-Small-Cell Lung Cancer Cell Lines. Mol Pharmacol 72:248-258; doi:10.1124/mol.107.034827.
    Mol Pharmacol; 2015 Aug; 88(2):390. PubMed ID: 26130289
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of o-phenylenediamine on methylglyoxal generation from monosaccharide: Comment on "correlation of methylglyoxal with acrylamide formation in fructose/asparagine Maillard reaction model system".
    Wang Y; Ho CT
    Food Chem; 2008 Jul; 109(1):1-3. PubMed ID: 26054257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrogen-bonding patterns in three substituted N-benzyl-N-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)acetamides.
    López G; Jaramillo LM; Abonia R; Cobo J; Glidewell C
    Acta Crystallogr C; 2010 Apr; 66(Pt 4):o168-73. PubMed ID: 20354301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.